Complete report spread across 89 pages available @ http://www.rnrmarketresearch.com/frontier-pharma-systemic-lupus-erythematosus-identifying-and-commercializing-first-in-class-innovation-market-report.html .

Scope

• The report analyzes the market for SLE therapeutics and the pipeline products in that market, with particular emphasis on first-in-class programs.

• A brief introduction to SLE, including symptoms, pathophysiology, disease scoring indices and overview of pharmacotherapy

• In-depth analysis and literature review on marketed products, including analyses of their safety, efficacy, treatment patterns and strengths/weaknesses, based on published clinical trials, as well as a reference table of drugs in terms of safety and efficacy

• Overview of how innovation products are contributing to the market for SLE therapeutics